← Back to headlines
Merck and Gilead Announce Positive Phase 3 Results for Combination HIV Pill
Pharmaceutical companies Merck and Gilead have reported positive outcomes from their Phase 3 clinical trials for a new combination pill designed to treat HIV.
8 Jun, 21:44 — 8 Jun, 21:44
Sources
Showing 1 of 1 sources
